Pages that link to "Q32060379"

The following pages link to Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products (Q32060379):

Displaying 50 items.

• In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor (Q27473320) (← links)
• Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes (Q27621649) (← links)
• Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain (Q27621765) (← links)
• High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants (Q27672908) (← links)
• The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase (Q28376948) (← links)
• In-cell protease assay systems based on trans-localizing molecular beacon proteins using HCV protease as a model system (Q28488653) (← links)
• Promising candidates for the treatment of chronic hepatitis C. (Q30333233) (← links)
• Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus (Q30746410) (← links)
• Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus (Q30843470) (← links)
• Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase). (Q30868173) (← links)
• Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals (Q30935094) (← links)
• Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain (Q30981037) (← links)
• Inhibiting viral proteases: challenges and opportunities (Q31112139) (← links)
• Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. (Q32020871) (← links)
• Hepatitis C virus: an overview of current approaches and progress (Q33755990) (← links)
• The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy (Q33801327) (← links)
• Perspectives for the treatment of infections with Flaviviridae (Q33812419) (← links)
• Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target (Q34003758) (← links)
• Increasing rate of cleavage at boundary between non-structural proteins 4B and 5A inhibits replication of hepatitis C virus (Q34074690) (← links)
• Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication (Q34797179) (← links)
• Viral protease inhibitors (Q34892265) (← links)
• Small Molecule Pan-Dengue and West Nile Virus NS3 Protease Inhibitors (Q34984021) (← links)
• Inhibitors of hepatitis C virus NS3.4A protease: an overdue line of therapy. (Q35049082) (← links)
• Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents? (Q35056049) (← links)
• Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitors (Q35092054) (← links)
• New therapies on the horizon for hepatitis C: are we close? (Q35105724) (← links)
• Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. (Q35116376) (← links)
• Hepatitis C virus therapies: current treatments, targets and future perspectives (Q35147050) (← links)
• Approaches to design non-covalent inhibitors for human granzyme B (hGrB). (Q35296702) (← links)
• Prospects for antiviral therapy (Q35625049) (← links)
• Recent developments in target identification against hepatitis C virus (Q35842500) (← links)
• The therapeutic potential of NS3 protease inhibitors in HCV infection (Q36249891) (← links)
• Blunting the Swiss army knife of hepatitis C virus: inhibitors of NS3/4A protease (Q36477461) (← links)
• Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation (Q37682862) (← links)
• The Journey to the Discovery of Boceprevir: An NS3–NS4 HCV Protease Inhibitor for the Treatment of Chronic Hepatitis C (Q37790484) (← links)
• The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure. (Q38269787) (← links)
• TimeSTAMP tagging of newly synthesized proteins (Q40001299) (← links)
• Prediction of substrate specificity in NS3/4A serine protease by biased sequence search threading (Q40778605) (← links)
• The characteristics of rare codon clusters in the genome and proteins of hepatitis C virus; a bioinformatics look (Q42172845) (← links)
• Molecular determinants of substrate specificity for Semliki Forest virus nonstructural protease (Q42424900) (← links)
• Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. (Q42537150) (← links)
• Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants (Q42980953) (← links)
• Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain. (Q42993945) (← links)
• Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein (Q42997262) (← links)
• Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer (Q42998590) (← links)
• Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies (Q43032593) (← links)
• Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease (Q43034042) (← links)
• Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor (Q43035640) (← links)
• A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease. (Q43036547) (← links)
• Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease (Q43036550) (← links)